Published in Int J Nanomedicine on September 12, 2011
Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis. Int J Nanomedicine (2013) 0.97
Immunotargeting of cancer stem cells. Contemp Oncol (Pozn) (2015) 0.85
Influence of nanomaterials on stem cell differentiation: designing an appropriate nanobiointerface. Int J Nanomedicine (2012) 0.84
Carbon nanotubes as vaccine scaffolds. Adv Drug Deliv Rev (2013) 0.84
Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer. J Nanobiotechnology (2013) 0.81
Antitumor effect of embryonic stem cells in a non-small cell lung cancer model: antitumor factors and immune responses. Int J Med Sci (2013) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Immunity, inflammation, and cancer. Cell (2010) 28.27
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science (2002) 19.77
Cancer immunotherapy: moving beyond current vaccines. Nat Med (2004) 17.61
Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol (2008) 10.77
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature (2003) 10.16
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol (2005) 6.95
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol (2006) 6.93
Longitudinal unzipping of carbon nanotubes to form graphene nanoribbons. Nature (2009) 4.73
CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev (2006) 4.49
Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood (2009) 4.13
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol (2010) 4.06
Immune therapy for cancer. Annu Rev Immunol (2009) 3.71
Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol (2009) 2.97
Cellular toxicity of carbon-based nanomaterials. Nano Lett (2006) 2.52
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev (2010) 2.41
Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano (2009) 2.39
Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett (2010) 2.35
Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol (2003) 2.28
Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J Immunol (2002) 1.93
Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomedicine (2009) 1.93
Inflammation, microenvironment, and the immune system in cancer progression. Curr Pharm Des (2009) 1.79
IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci U S A (2005) 1.70
TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice. J Clin Invest (2007) 1.63
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity. Blood (2009) 1.57
Evolving treatment of advanced colon cancer. Annu Rev Med (2009) 1.56
Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev (2004) 1.55
Clinical biochemistry parameters in C57BL/6J mice after blood collection from the submandibular vein and retroorbital plexus. J Am Assoc Lab Anim Sci (2010) 1.43
Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody. Clin Cancer Res (2009) 1.35
Direct interferon-gamma signaling dramatically enhances CD4+ and CD8+ T cell memory. J Immunol (2007) 1.27
Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol (1999) 1.26
Targeted therapies to improve tumor immunotherapy. Clin Cancer Res (2008) 1.25
Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody. Nanomedicine (2010) 1.22
In situ detection of apoptosis by the TUNEL assay: an overview of techniques. Methods Mol Biol (2011) 1.17
Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy. Small (2008) 1.17
Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity. Clin Cancer Res (2010) 1.14
The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci (2004) 1.14
Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer. Oncol Rep (2009) 1.11
The effect of magnetic nanoparticles of Fe(3)O(4) on immune function in normal ICR mice. Int J Nanomedicine (2010) 1.08
Rapid photothermal intracellular drug delivery using multiwalled carbon nanotubes. Mol Pharm (2009) 1.06
Photothermal response of human and murine cancer cells to multiwalled carbon nanotubes after laser irradiation. Cancer Res (2010) 1.05
Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer. Stem Cells (2009) 1.03
Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm. J Natl Cancer Inst (1998) 0.98
Virus-sized vaccine delivery systems. Drug Discov Today (2008) 0.93
Embryonic vaccines against cancer: an early history. Exp Mol Pathol (2009) 0.93
IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response. J Immunol (2010) 0.93
Antitumor vaccines, immunotherapy and the immunological constant of rejection. IDrugs (2009) 0.92
Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells. J Clin Invest (2010) 0.92
Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli. Nano Lett (2008) 0.92
Organic functionalization of single-walled carbon nanotubes (SWCNTs) with some chemotherapeutic agents as a potential method for drug delivery. Int J Nanomedicine (2010) 0.91
Clustering of stimuli on single-walled carbon nanotube bundles enhances cellular activation. Langmuir (2010) 0.89
Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy. Cancer Chemother Pharmacol (2008) 0.86
Administration of embryonic stem cells generates effective antitumor immunity in mice with minor and heavy tumor load. Cancer Immunol Immunother (2010) 0.85
Carbon-covered magnetic nanomaterials and their application for the thermolysis of cancer cells. Int J Nanomedicine (2010) 0.80
Open or laparoscopic treatment for hydatid disease of the liver? A 10-year single-institution experience. Surg Endosc (2013) 1.57
Mixed hepatoblastoma in child. Case report. Med Ultrason (2010) 0.94
Implementing fast-track protocol for colorectal surgery: a prospective randomized clinical trial. World J Surg (2009) 0.93
Synergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug. Nanomedicine (Lond) (2009) 0.92
Surface plasmon resonance-induced photoactivation of gold nanoparticles as mitochondria-targeted therapeutic agents for pancreatic cancer. Expert Opin Ther Targets (2013) 0.91
The role of i.v. and oral contrast enhanced ultrasonography in the characterization of gastric tumors. A preliminary study. Med Ultrason (2012) 0.90
Staging laparoscopy in gastric cancer. Accuracy and impact on therapy. J Gastrointestin Liver Dis (2009) 0.89
The safety of endoscopic ultrasonography-guided drainage of pancreatic fluid collections without fluoroscopic control: a single tertiary center experience. J Gastrointestin Liver Dis (2011) 0.88
Cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines. J Appl Toxicol (2010) 0.87
Long term outcome following surgical treatment for distal gastric cancer. J Gastrointestin Liver Dis (2013) 0.87
Alkaline reflux esophagitis in patients with total gastrectomy and Roux en Y esojejunostomy. J Gastrointestin Liver Dis (2010) 0.85
Contrast enhanced ultrasound and computer tomography diagnosis of solid and mixed pancreatic tumors - analysis of confounders. J Gastrointestin Liver Dis (2012) 0.84
Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma. Proteomics (2014) 0.83
Added value of intravenous contrast-enhanced ultrasound for characterization of cystic pancreatic masses: a prospective study on 37 patients. Med Ultrason (2012) 0.82
Selective ex-vivo photothermal ablation of human pancreatic cancer with albumin functionalized multiwalled carbon nanotubes. Int J Nanomedicine (2011) 0.82
Laparoscopic resection of duodenal diverticulum. A case report. Rom J Gastroenterol (2005) 0.81
Double splenic artery pseudoaneurysm associating splenic infarction in chronic pancreatitis. J Gastrointestin Liver Dis (2012) 0.81
Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate. J Gastrointestin Liver Dis (2013) 0.80
Nicotinamide-functionalized multiwalled carbon nanotubes increase insulin production in pancreatic beta cells via MIF pathway. Int J Nanomedicine (2013) 0.79
Biliary plastic stent as a matrix core for lithogenesis in the common bile duct: a rare cause of jaundice. J Gastrointestin Liver Dis (2012) 0.78
Minimal invasive treatment of abdominal multiorgan echinococcosis. Int Surg (2013) 0.78
Radial endoscopic ultrasonography in the preoperative staging of pancreatic cancer. J Gastrointestin Liver Dis (2008) 0.77
NAT2 polymorphisms and sporadic colorectal cancer survival. J Gastrointestin Liver Dis (2010) 0.77
Selective Laser Ablation of Methicillin-Resistant Staphylococcus Aureus with IgG Functionalized Multi-Walled Carbon Nanotubes. J Biomed Nanotechnol (2016) 0.77
Raman spectroscopy as a detection and analysis tool for in vitro specific targeting of pancreatic cancer cells by EGF-conjugated, single-walled carbon nanotubes. J Appl Toxicol (2011) 0.77
Laparoscopic low anterior resection with total mesorectal excision for rectal cancer. Hepatogastroenterology (2012) 0.75
The influence of circumferential resection margins on survival following rectal cancer surgery. Ann Ital Chir (2016) 0.75
Professor Dr. Sergiu Duca -- a pathbreaker. Chirurgia (Bucur) (2015) 0.75
C677T and A1298C mutations in the MTHFR gene and survival in colorectal cancer. J Gastrointestin Liver Dis (2009) 0.75
Laparoscopic rectal resection versus conventional open approach for rectal cancer - a 4-year experience of a single center. J BUON (2016) 0.75
Role of computer tomography and endoscopic ultrasonography in assessing portal and superior mesenteric vessels invasion in cephalo-pancreatic adenocarcinoma. Ann Ital Chir (2017) 0.75
Gallbladder carcinoma. A clinical study of a series of 38 cases. Rom J Gastroenterol (2003) 0.75
Minimally invasive esophagectomy by video-assisted thoracoscopic approach for esophageal carcinoma. A case report. J Gastrointestin Liver Dis (2006) 0.75
Thoracoscopic and laparoscopic esophagectomy with cervical manual anastomosis for esophageal cancer. Hepatogastroenterology (2012) 0.75